UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041310
Receipt number R000047168
Scientific Title Development of a new device for improving accuracy and feasibility in neuromuscular monitoring with acceleromyography: a prospective randomized trial
Date of disclosure of the study information 2020/10/01
Last modified on 2023/08/07 09:30:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of a new device for improving accuracy and feasibility in neuromuscular monitoring with acceleromyography: a prospective randomized trial

Acronym

Development of a new device for improving accuracy and feasibility in neuromuscular monitoring with acceleromyography: a prospective randomized trial

Scientific Title

Development of a new device for improving accuracy and feasibility in neuromuscular monitoring with acceleromyography: a prospective randomized trial

Scientific Title:Acronym

Development of a new device for improving accuracy and feasibility in neuromuscular monitoring with acceleromyography: a prospective randomized trial

Region

Asia(except Japan)


Condition

Condition

neuromuscular blockade monitoring during lumbar spinal surgery

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the precision and performance of
acceleromyography performed with the aid of a newly developed wrist brace
with standard electromyography (EMG).

Basic objectives2

Others

Basic objectives -Others

To compare the precision and performance of
acceleromyography performed with the aid of a newly developed wrist brace
with standard electromyography (EMG).

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The precision (i.e., variance during recovery to at least an accelomyographic TOF 0.90) between the group with brace and the group without brace compared with EMG.

Key secondary outcomes

The difference (agreement) of the two groups (with brace and without brace) against the EMG (Bland-Altman plots).


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Neuromuscular transmission monitoring during baseline, onset and spontaneous recovery of rocuronium-induced neuromuscular block using accelomyography with wrist brace/Neuromuscular transmission monitoring during baseline, onset and spontaneous recovery of rocuronium-induced neuromuscular block using EMG.

Interventions/Control_2

Neuromuscular transmission monitoring during baseline, onset and spontaneous recovery of rocuronium-induced neuromuscular block using accelomyography without wrist brace/Neuromuscular transmission monitoring during baseline, onset and spontaneous recovery of rocuronium-induced neuromuscular block using EMG.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with ASA physical status 1-2, undergoing elective lumbar spine surgery.

Key exclusion criteria

Patients were excluded if they had a known hypersensitivity to the drugs used in this study, known neuromuscular disease, significant hepatic or renal dysfunction, cerebrovascular disease, or a body mass index >30.0 kg m-2.
Patients with hemodynamic instability with an increase or decrease in blood pressure of 30% or more of the baseline over 15 minutes during surgery, and blood loss of 1L or more during surgery.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Byung Gun
Middle name
Last name Lim

Organization

Department of Anesthesiology and Pain Medicine, Korea University Guro Hospital

Division name

Seoul

Zip code

08308

Address

148, Gurodong-ro, Guro-gu, Seoul, Republic of Korea

TEL

82-2-2626-3231

Email

bglim9205@korea.ac.kr


Public contact

Name of contact person

1st name Seok Kyeong
Middle name
Last name Oh

Organization

Department of Anesthesiology and Pain Medicine, Korea University Guro Hospital

Division name

Seoul

Zip code

08308

Address

148, Gurodong-ro, Guro-gu, Seoul, Republic of Korea

TEL

82-2-2626-1437

Homepage URL


Email

nanprayboy@korea.ac.kr


Sponsor or person

Institute

Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea

Institute

Department

Personal name



Funding Source

Organization

Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Korea University Guro Hospital Institutional Review Board, Seoul, Republic of Korea

Address

Korea University Guro Hospital, 148, Gurodong-ro, Guro-gu, Seoul 08308, Republic of Korea

Tel

82-2-2626-1632

Email

kughirb@naver.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 01 Day


Related information

URL releasing protocol

https://link.springer.com/article/10.1007/s10877-023-01000-w

Publication of results

Published


Result

URL related to results and publications

https://link.springer.com/article/10.1007/s10877-023-01000-w

Number of participants that the trial has enrolled

57

Results

The agreement between AMG and EMG in each group was assessed using the Bland Altman method. In group B, the repeatability coefficient of T1 was significantly lower during the recovery to T1 of 25% and TOF ratio of 0.9 (P  0.017 and 0.033, respectively), indicating higher precision. The mean differences of bias between AMG and EMG in TOF ratio of 0.9 were 6.839 in group NB and 3.922 in group B. The wide limits of agreement in group NB was slightly narrowed in group B but without significance.

Results date posted

2023 Year 08 Month 07 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2023 Year 04 Month 01 Day

Baseline Characteristics

Patients aged 19 to 75 years with American Society of Anesthesiologists physical status I or II who underwent elective lumbar spine surgery were included. Patients were excluded if they had known hypersensitivity to the drugs used in this study, neuromuscular disease, significant hepatic or renal dysfunction, cerebrovascular disease, or body mass index > 30.0. Patients who required intraoperative neurophysiological monitoring, including motor-evoked potentials, were also excluded.

Participant flow

The patients were randomly assigned to groups in which AMG with a wrist brace (group B) or without a wrist brace (no brace; group NB) was applied to an arm using a web-based computer-generated list. The randomized numbers were kept in opaque, sealed envelopes and opened in the operating room by an independent anesthesiologist.

Adverse events

No severe adverse event.

Outcome measures

Fifty seven patients, undergoing lumbar surgery under general anesthesia, were randomly assigned to groups to which AMG was applied with or without (no) brace (29 in group B vs. 28 in group NB). EMG was performed in the contralateral arm. Repeatability coefficients of the first twitch height (T1) and TOF ratio were assessed from nine consecutive measurements during spontaneous recovery from rocuronium-induced neuromuscular block and the AMGs of the two groups were compared in prone position.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 11 Month 01 Day

Date of IRB

2019 Year 11 Month 12 Day

Anticipated trial start date

2019 Year 11 Month 12 Day

Last follow-up date

2021 Year 05 Month 06 Day

Date of closure to data entry

2021 Year 12 Month 12 Day

Date trial data considered complete

2022 Year 05 Month 01 Day

Date analysis concluded

2022 Year 05 Month 01 Day


Other

Other related information



Management information

Registered date

2020 Year 08 Month 04 Day

Last modified on

2023 Year 08 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047168


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name